Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.

Main|Search|PHGKB






Last Posted: Oct 06, 2018

---

• Secondary findings from clinical genomic sequencing: prevalence, patient perspectives, family history assessment, and health-care costs from a multisite study.
  Hart M Ragan et al. Genetics in medicine : official journal of the American College of Medical Genetics 2018 Oct
• Exploring neurologists' perspectives on the return of next generation sequencing results to their patients: a needed step in the development of guidelines.
  Hurlimann Thierry et al. BMC medical ethics 2018 Sep 19(1) 81
• The importance of genetic counselling in genome-wide sequencing
  AM Elliot et al, October 3, 2018
• Disclosure of Individual Research Results and Incidental Findings in Biobank Research: Why We Need an Evidence-based Approach.
  Fleming Jennifer et al. Journal of law and medicine 24(1) 89-95
• Clinical Impact of KRAS and GNAS Analysis Added to CEA and Cytology in Pancreatic Cystic Fluid Obtained by EUS-FNA.
  Faias Sandra et al. Digestive diseases and sciences 2018 63(9) 2351-2361
• Laboratory considerations for prenatal genetic testing.
  Wou Karen et al. Seminars in perinatology 2018 Jul
• User Acceptability of Whole Exome Reproductive Carrier Testing for Consanguineous Couples in Australia.
  Josephi-Taylor Sarah et al. Journal of genetic counseling 2018 Sep
• Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature.
  Delanne J et al. European journal of medical genetics 2018 Aug
• Genetic testing in children and adolescents with intellectual disability.
  Bass Nick et al. Current opinion in psychiatry 2018 Aug
• [Ethical dilemmas in a general practitioner's clinic due to incidental findings resulting from whole genome sequencing].
  Wouters Roel H P et al. Nederlands tijdschrift voor geneeskunde 2018 Jun 162

more